FDA Inspection 1077867 — Natera, Inc.
The FDA completed an inspection of Natera, Inc. on November 8, 2018 in San Carlos, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 8, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- San Carlos, CA (United States)